Mandate

Vinge advises the sellers in connection with the divestment of Johan i Hallen & Bergfalk

May 04, 2023 Banking and Finance M&A

Vinge advises the sellers, represented by Litorina V Fund, in connection with the divestment of JOHBECO AB (including its Swedish and Finnish subsidiaries Johan i Hallen & Bergfalk) to METRO FSD Holding GmbH, an indirect subsidiary of international wholesaler METRO AG.

Johan i Hallen & Bergfalk operates on the Swedish and Finnish markets and is a leading Swedish specialist provider of high quality fresh proteins such as meat, fish and seafood to restaurants, hotels and cafés.

Vinge’s team consisted of Jonas Johansson, Carl Sander, Desirée Hagenfeldt and Robin Sultani (M&A) and Karl-Gustaw Tobola (Bank & Financing) as well as Julia Hagelberg, Emy Rydén and Anna Ekdahl Roos (project assistants).

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024